Pharmaceutical products

Description

PBL has a requirement for a contract manufacturing organisation (CMO) to manufacture a recombinant protein, expressed in bacteria. The project will include technical transfer and manufacture of clinical-grade GMP drug substance and drug product. Parties interested in either or both stages (drug substance and/or drug product) should reply and agree to exchange a CDA prior to the tender. PBL has a requirement for a contract manufacturing organisation (CMO) to manufacture a recombinant protein, expressed in bacteria. The project will include technical transfer and manufacture of clinical-grade GMP drug substance and drug product. Parties interested in either or both stages (drug substance and/or drug product) should reply and agree to exchange a CDA prior to the tender. PBL has a requirement for a contract manufacturing organisation (CMO) to manufacture a recombinant protein, expressed in bacteria. The project will include technical transfer and manufacture of clinical-grade GMP drug substance and drug product. Parties interested in either or both stages (drug substance and/or drug product) should reply and agree to exchange a CDA prior to the tender. PBL has a requirement for a contract manufacturing organisation (CMO) to manufacture a recombinant protein, expressed in bacteria. The project will include technical transfer and manufacture of clinical-grade GMP drug substance and drug product. Parties interested in either or both stages (drug substance and/or drug product) should reply and agree to exchange a CDA prior to the tender.